This study tests an inhaled medication called LAM-001 (sirolimus) in 85 adults with pulmonary hypertension caused by interstitial lung disease. The goal is to see if it improves blood flow in the lungs and is safe to use alongside standard treatments. Participants are randomly as…
Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:21 UTC